CRBP icon

Corbus Pharmaceuticals
CRBP

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$44
434% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
RBC Capital
RBC Capital
Brian Abrahams
50% 1-yr CRBP win rate
13 Nov ‘25 2 months ago
Wedbush
Wedbush
Robert Driscoll
0% 1-yr CRBP win rate
20 Oct ‘25 2 months ago
HC Wainwright & Co
HC Wainwright & Co
Andres Maldonado
50% 1-yr CRBP win rate
20 Oct ‘25 2 months ago